Quarterly Report • Nov 27, 2024
Quarterly Report
Open in ViewerOpens in native device viewer

1 January – 30 September 2024


____________________________________
1 January to 30 September 2024
| Report and Endorsement by the Board of Directors and the CEOs | 3 |
|---|---|
| Condensed Consolidated Interim Income statement | 6 |
| Condensed Consolidated Interim Statement of Comprehensive Income | 7 |
| Condensed Consolidated Interim Statement of Financial Position | 8 |
| Condensed Consolidated Interim Statement of Changes in Equity | 9 |
| Condensed Consolidated Interim Statement of Cash Flows | 10 |
| Notes to the Condensed Consolidated Interim Financial Statements | 11 |

The condensed consolidated interim financial statements of Vátryggingafélag Íslands hf. ("the Company" or "Skagi") for the period 1 January to 30 September 2024 consist of the financial statements of the Company and its subsidiaries. Subsidiaries include Fossar fjárfestingarbanki hf. ("Fossar" or "the bank"), SIV eignastýring hf. (SIV), and Líftryggingafélag Íslands hf. (Lífís), collectively with the Company referred to as "the Group". The Group's operations consist of insurance activities, investment banking activities and asset and fund management. The financial statements are prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU and the additional requirements for companies listed on a regulated securities market. The condensed consolidated interim financial statements have not been reviewed or audited by Independent Auditors of the Company.
According to the Income Statement the Group's profit for first nine months 2024 amounted to ISK 700 million. The Group's assets at the end of the period amounted to ISK 72,835 million and equity amounted to ISK 20,403 million according to the balance sheet.
A significant operational improvement has taken place in the insurance business. This can be attributed to more new customers as well as increased insurance sales to existing customers. Insurance business generated growth in insurance revenue with a combined ratio of 95.2% (9M 2023: 100.5%). In Q3 2024 the combined ratio was 92.3% compared to 94.7% in the same period in the prior year. Income growth in life and health insurance is about 15.0% year-on-year. The insurance service result was positive by ISK 1,042 million, versus a negative figure of ISK 102 million last year. This 1,144 million positive turnaround between years is the result of a changed focus, as the Company's sales structure was transformed, and investment was made in new digital sales channels.
The insurance contracts expense ratio is decreasing, coming in at 18.9% for the first nine months of this year versus 21.8% at the same time last year. The claims ratio was 73.3% (9M 2023: 75.7%), net reinsurance ratio was 3,0% (9M 2023: 3,0%).
Financial services activities, which consist of the operations of Fossar and SIV, generated net income of 1,452 million and loss before tax of -150 million in the first nine months of 2024. Important milestones have been achieved during this period as the bank's share of the bond market continued to increase, the bank's interest rate margin became more stable, and the loan book continued to grow in line with expectations. Since the beginning of the year, the balance sheet has grown by 52% and the bank's lending has increased by ISK 2.7 billion at the same time. The bank has now issued its first listed bond for ISK 1.5 billion with term of 18 months on floating rates and recently issued a bond for 1.5 billion for 18 months at fixed rates. The bank is taking important steps towards becoming a reliable issuer on the bond market.
Financial services activities also generated significant growth in net income in the first nine months of the year compared to the prior year with pro forma growth of 86% between years. The net income of financial activities totalled around ISK 1.452 million, compared to ISK 779 million pro forma last year. It should be noted that SIV's activities did not begin until the second half of last year. The financial activities are therefore on a strong growth path.
Assets under management (AuM) at the Skagi Group stand at 123 billion at the end of Q3 2024. AUM of Skagi will increase significantly after the acquisition with Íslensk verðbréf hf. has been completed, at which time AUM will be around ISK 224 billion, representing a 92% growth since the end of last year.

The return on the insurance investment assets in the first nine months of 2024 was 4.6% (9M 2023: 7.6%). Investments generated financial income of 2,011 million (9M 2023: 3,255) and net financial income of 560 million (9M 2023: 1.975 million). Controlant share price drop in the quarter negatively aƯects the return by an amount of 417 million representing a 0.9% drawdown on the total investment portfolio (share price reduced from 80 USD per share down to 30 USD per share).
Guidance on target operating performance for the fiscal year 2024 is as follows:
An update will be provided to investors if performance is expected to be outside of the target range for Insurance business and financial services, however no update will be provided on expected return for the insurance investment assets.
The Company's nominal shares amounted to ISK 1,906.7 million at period end (own shares amounting to ISK 28,9 million), with each share having a nominal value of ISK 1. There were 913 shareholders at the beginning of the period and 882 shareholders at the end of it. The board of directors' proposal for the payment of a dividend in the amount of ISK 1,000 million or ISK 0.524 per share was approved at the Company's Annual General Meeting on 21st March and the company paid the dividend to shareholders on 2nd April 2024.
Skagi has signed purchase agreements to acquire Íslensk verðbréf hf. (ÍV). The company, that was founded in 1987, oƯers services in the fields of capital markets, asset management and fund management and currently has about 101 billion ISK of AUM at the end of Q3 2024. Around 4,000 clients have funds under asset management and in custody at ÍV.
Skagi's acquisition of ÍV was agreed subject to the approval of the Financial Supervisory Authority of the Central Bank of Iceland ("FSA") and the Icelandic Competition Authority ("ICA"). The approval of both the FSA and ICA has has now been obtained, and the acquisition was concluded on 11th November 2024. Hence, ÍV will become part of the consolidated financial statements of Skagi as of Q4 2024.

To the best knowledge of the board the consolidated interim financial statements of Vátryggingafélag Íslands hf. give a true and fair view of the consolidated financial performance of the Group for the period 1 January to 30 September 2024, and its assets, liabilities, and financial position as of 30 September 2024. Further, in our opinion the consolidated interim financial statements give a fair view of the development and performance of the Group's operations and its position at the end of the period and describe the principal risks faced by the Group.
The Board of Directors and the CEOs have today discussed the Company's Condensed Consolidated Interim Financial Statements of Vátryggingafélag Íslands hf. for the period ended 30 September 2024 and confirm by means of their signatures.
Reykjavik, 27 November 2024
| Stefán Héðinn Stefánsson | Vilhjálmur Egilsson |
|---|---|
| Chairman of the Board | Vice-Chairman of the Board |
| Marta Guðrún Blöndal | Ásgeir Helgi Reykfjörð Gylfason |
| Hrund Rudolfsdóttir | |
| CEOs |
Haraldur Þórðarson Guðný Helga Herbertsdóttir

| Condensed Consolidated Interim Income Statement | |||||
|---|---|---|---|---|---|
| For the period 1 January to 30 September 2024 | |||||
| Notes | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 | |
| Insurance revenue | 7.634.285 | 6.952.232 | 21.636.007 | 19.630.537 | |
| Insurance expenses | (5.613.013) | (5.047.992) | (15.869.322) | (14.864.283) | |
| Insurance contract operating expenses | (1.244.001) | (1.296.829) | (4.083.774) | (4.278.436) | |
| Net expenses from reinsurance contracts | (187.636) | (238.933) | (640.491) | (589.756) | |
| Insurance service result | 6 | 589.635 | 368.479 | 1.042.420 | (101.938) |
| Interest income | 412.221 | 0 | 1.118.864 | 0 | |
| Interest expenses | (349.524) | 0 | (959.051) | 0 | |
| Net interest income | 7 | 62.697 | 159.813 | 0 | |
| Fee and commission income | 312.832 | 0 | 1.190.234 | 0 | |
| Fee and commission expenses | (7.727) | 0 | (54.029) | 0 | |
| Net fee and commission income | 8 | 305.105 | 0 | 1.136.205 | 0 |
| Net financial income | 9 | 119.137 | 387.677 | 587.292 | 1.975.201 |
| Other operating income | 16.617 | 35.627 | 78.589 | 77.761 | |
| Other net operating income | 135.753 | 423.305 | 665.881 | 2.052.961 | |
| Net operating income | 1.093.190 | 791.783 | 3.004.318 | 1.951.023 | |
| Operating expenses Net impairments |
10 | (651.993) (650) |
(79.423) 0 |
(2.065.510) (9.450) |
(203.521) 0 |
| Profit before tax | 440.547 | 712.360 | 929.358 | 1.747.502 | |
| Income tax expenses | 11 | (13.330) | (104.888) | (229.283) | (67.838) |
| Profit and net profit for the period | 427.217 | 607.471 | 700.074 | 1.679.664 | |
| Profit attributable to shareholders | 425.807 | 613.957 | 701.422 | 1.693.417 | |
| Profit attributable to minority interest | 1.410 | (6.486) | (1.348) | (13.753) | |
| Total profit for the period | 427.217 | 607.471 | 700.074 | 1.679.664 | |
| Earnings per share | |||||
| Basic and diluted earnings per share | 0,23 | 0,35 | 0,37 | 0,98 | |

| For the period 1 January to 30 September 2024 | ||
|---|---|---|
| YTD 2024 | YTD 2023 | |
| Profit for the period | 700.074 | 1.679.664 |
| Other Comprehensive income Items that are or may be reclassified subsequently to profit and loss and relocated to equity |
||
| Reclassification of fair value changes to income statement Unrealised fair value changes |
(5.121) (1.983) |
0 0 |
The notes on pages 11-30 are an integral part of these financial statements.
| Condensed Consolidated Interim Statement of Financial Position | |||
|---|---|---|---|
| As at 30 September 2024 | |||
| Notes | 30.9.2024 | 31.12.2023 | |
| Assets | |||
| Cash and cash equivalents | 1.836.096 | 2.270.693 | |
| Financial assets of insurance activites Securities for hedging purposes |
12 13 |
45.050.792 5.631.144 |
42.758.589 4.521.114 |
| Forward contracts | 14 | 188.883 | 143.235 |
| Equities and other securities | 26 | 403.288 | 337.320 |
| Bonds | 26 | 5.574.278 | 4.562.123 |
| Loans to customers | 26,28,29 | 4.406.929 | 1.672.720 |
| Investments where investment risk is | |||
| borne by life-insurance policyholders | 1.055.384 | 1.047.382 | |
| Share in associates | 16 | 174.883 | 190.283 |
| Goodwill and other intangible assets | 17 | 3.408.574 | 3.483.211 |
| Right-of-use asset Operating assets |
397.635 343.699 |
584.453 329.531 |
|
| Deferred income tax asset | 280.997 | 191.211 | |
| Reinsurance contract assets | 1.322.546 | 1.229.156 | |
| Other receivables | 18 | 2.759.861 | 2.146.748 |
| Total assets | 72.834.988 | 65.467.768 | |
| Liabilities | |||
| Liabilities due to insurance contracts Provisions for investment contracts |
19 | 28.440.693 1.055.384 |
26.162.186 1.047.382 |
| Subordinated bond | 20 | 3.705.666 | 3.589.584 |
| Money market loans | 26 | 9.274.046 | 6.227.385 |
| Issued bonds and bills | 26 | 3.563.529 | 2.285.315 |
| Liabilities to credit institutions | 26 | 1.399.242 | 700.000 |
| Forward contracts | 14 | 244.681 | 215.615 |
| Lease liability | 440.059 | 636.966 | |
| Deferred income tax liability | 274.537 | 271.629 | |
| Accounts payable and other liabilities Total liabilities |
21 | 4.034.015 52.431.850 |
3.159.773 44.295.835 |
| Equity | |||
| Share capital | 22 | 1.877.737 | 1.905.550 |
| Share premium account | 3.087.000 | 3.087.000 | |
| Statutory reserve | 625.620 | 625.620 | |
| Restricted reserves Retained earnings |
1.225.346 13.543.780 |
3.852.262 11.660.499 |
|
| Total equity attributible to shareholders | 20.359.483 | 21.130.931 | |
| Minority interest | 43.655 | 41.002 | |
| Total equity | 20.403.138 | 21.171.933 | |
| Total liabilities and equity | 72.834.988 | ||
| 65.467.768 |
The notes on pages 11-30 are an integral part of these financial statements.
| Condensed Consolidated Interim Statement of Changes in Equity | |||||||
|---|---|---|---|---|---|---|---|
| For the period 1 January to 30 September 2024 | |||||||
| Share capital |
Share premium |
Statutory reserve |
Restricted reserve |
Retained earnings |
Minority interest |
Total | |
| 2023 Equity 1.1.2023 Total comprehensive income for the period |
1.715.600 | 625.620 | 6.671.783 | 8.265.816 1.693.417 |
45.960 (13.753) |
17.324.779 1.679.664 |
|
| Change of holding in subsidiary Treasury shares purchased Dividends paid, ISK 0,554 per share |
(20.050) | 0 (332.335) (939.335) |
6.000 | 6.000 (352.385) (939.335) |
|||
| Restricted reserve for securites Equity 30.9.2023 |
1.695.550 | 0 | 625.620 | (3.492.869) 3.178.914 |
3.492.869 12.180.431 |
38.207 | 0 17.718.723 |
| 2024 Equity 1.1.2024 |
1.905.550 | 3.087.000 | 625.620 | 3.852.262 | 11.660.499 701.422 |
41.002 (1.348) |
21.171.933 700.074 |
| Total comprehensive income for the period | |||||||
| Change of holding in subsidiary Treasury shares purchased Dividends paid, ISK 0,524 per share Restricted reserve for securites Stock options |
(27.813) | (2.626.916) | (472.187) (984.809) 2.618.322 20.533 |
4.000 | 4.000 (500.000) (984.809) (8.594) 20.533 |
The notes on pages 11-30 are an integral part of these financial statements.

| Condensed Consolidated Interim Statement of Cash Flows For the period 1 January to 30 September 2024 |
|||
|---|---|---|---|
| Notes | YTD 2024 | YTD 2023 | |
| Operating activities | |||
| Profit for the period | 700.074 | 1.679.664 | |
| Operating items not affecting cash flows: | |||
| Net interest income | (159.813) | 0 | |
| Financial income | (2.038.682) | (3.254.684) | |
| Net finance expense from insurance contracts | 920.226 | 668.611 | |
| Deferred tax, change | (86.878) | (13.582) | |
| Forward contracts, change | (16.583) | 0 | |
| Stock options | 20.533 | 0 | |
| Profit on sale of operating assets | (3.420) | (6.014) | |
| Depreciation and amortisation | 405.185 | 453.694 | |
| Changes in operating assets and liabilities: | |||
| Financial assets, change | (552.116) | 1.139.633 | |
| Reinsurance assets, change | (93.391) | (45.611) | |
| Securities, change | (2.196.746) | 0 | |
| Loans to customers, change | (2.734.209) | 0 | |
| Other receivables, change | (597.713) | (2.489.924) | |
| Insurance contract liabilities, change | 1.447.861 | 3.417.946 | |
| Accounts payable and other liabilities, change | 919.804 | (88.306) | |
| Cash flows from operating activities before interest and tax | (4.065.865) | 1.461.426 | |
| Interest income received | 1.177.761 | 605.453 | |
| Dividend received | 239.036 | 0 | |
| Financial expenses paid | (932.549) | (517.449) | |
| Income taxes paid | (45.563) | (194.537) | |
| Cash flows from operating activities | (3.627.180) | 1.354.895 | |
| Investing activities | |||
| Purchase of operating assets | (137.353) | (55.670) | |
| Sale of operating assets | 3.712 | 25.200 | |
| Purchase of intangible assets | 17 | (32.786) | (125.749) |
| Sale of shares in subsidiary | 4.000 | 6.000 | |
| (162.429) | (150.220) | ||
| Financing activities | |||
| Purchase of treasury shares | (500.000) | (352.385) | |
| Dividends paid | (984.809) | (939.335) | |
| Principal payments of lease liability Short-term loans, change |
(184.958) 5.024.117 |
(118.770) 0 |
|
| 3.354.350 | (1.410.490) | ||
| Change in cash and cash equivalents | (435.258) | (205.815) | |
| Cash and cash equivalents at the beginning of the year | 2.270.693 | 2.380.526 | |
| Effect of movements in exchange rates on cash held | 659 | 7.325 | |
| Cash and cash equivalents at year end | 1.836.096 | 2.182.036 |
The notes on pages 11-30 are an integral part of these financial statements.
| 1. | Reporting entity 12 | |
|---|---|---|
| 2. | Basis of preparation 12 | |
| 3. | Functional and presentation currency 12 | |
| 4. | Accounting estimates 13 | |
| Operating segment reporting 13 |
|---|
| 6. | Insurance service result 14 | |
|---|---|---|
| 7. | Net interest income 15 | |
| 8. | Net fee and commission income 15 | |
| 9. | Net financial income 15 | |
| 10. | Operating expenses 16 | |
| 11. | Income tax 16 |
| 12. | Financial assets of insurance activities 17 |
|---|---|
| 13. | Securities for hedging purposes 17 |
| 14. | Forward contracts 17 |
| 15. | Share in subsidiaries 17 |
| 16. | Share in associates 18 |
| 17. | Intangible assets 18 |
|---|---|
| 18. | Other receivables 18 |
| 19. | Insurance contract liabilities 19 |
| 20. | Subordinated bond 19 |
| 21. | Accounts payable and other liabilities 19 |
| 22. | Share capital and equity reserves 20 |
| 23. | Fossar Capital adequacy ratio 20 |
| 24. | Solvency of a financial conglomerate 21 |
| 25. | Solvency of insurance activities 21 |
| 26. | Financial instruments 22 |
| 27. | Credit quality of financial assets 24 |
| 28. | Loan-to-value 26 |
| 29. | Maximum exposure to credit risk 27 |
| 30. | Collateral against exposures to derivatives 28 |
| 31. | Large exposure 29 |
| 32. | Key ratios 29 | |
|---|---|---|
| 33. | Related parties 29 | |
| 34. | Events after the reporting date 30 | |
| 35. | Quarterly statement 30 |
Vátryggingafélag Íslands hf., the Parent Company, hereinafter referred to as "the Company" or "Skagi", is a limited liability company and operates on the basis of Act No. 100/2016 on Insurance Activities, Act No. 2/1995 on Limited Liability Companies and Act No. 161/2002 on Financial Undertakings. The Company's headquarters are at Ármúli 3, Reykjavík.
On 17th January 2024 a shareholders meeting of the Company was held whereas a change of the Company name from "Vátryggingafélag Íslands hf." to a new name "Skagi hf." was approved. The change of name to Skagi hf. in company registry in Iceland will not be concluded until transfer of the insurance operations into a subsidiary has been finalized.
A purchase agreement for the Company's insurance operations has been concluded between Skagi and VÍS tryggingar hf.; the agreement is subject to the approval of a shareholders' meeting for the transfer of the insurance operations (which was approved at a shareholders meeting on 17th January 2024) and the approval of the Financial Supervisory Authority of the Central Bank of Iceland for the transfer of the insurance portfolio and the insurance operations to a subsidiary, which remains outstanding. The Company expects that the transfer of the Company's insurance operations to VÍS tryggingar hf. will take place in 2024.
The condensed consolidated interim financial statements of Vátryggingafélag Ísland ("consolidated financial statements") comprise the interim financial statements of Vátryggingafélag Íslands ("Skagi" or the "Parent Company") which includes the insurance business of VÍS ("VÍS") and its subsidiaries, Líftryggingafélag Íslands ("Lífís"), SIV Asset Management ("SIV") and Fossar Investment Bank ("Fossar"). The Company and its subsidiaries are collectively referred to as the "Group". The Group operates in the fields of non-life insurance, life insurance, investments, asset management and investment banking. The Icelandic Financial Supervisory Authority supervises the Group's operations based on Act No. 87/1998 on OƯicial Supervision of Financial Activities.
The condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard IAS 34 Interim Financial Reporting, as adopted by the European Union and additional requirements according to the Icelandic Financial Statements Act. The interim financial statements were approved and authorized for publication at a meeting of the Board of Directors on 27 November 2024. The condensed consolidated interim financial statements do not contain all the information required in consolidated financial statements and should be read in conjunction with its annual consolidated financial statements for the year 2023, which are available at www.skagi.is.
The condensed consolidated interim financial statements are prepared and presented in Icelandic krónur (ISK), which is the Company's functional currency. All amounts are presented in thousands of ISK unless otherwise stated.
Preparing condensed consolidated interim financial statements in accordance with IFRS requires management to make assumptions, estimates and apply judgement that aƯect the assets and liabilities at the reporting date, disclosures in notes and income and expenses. Estimates and judgements are based on experience and various other factors that are considered appropriate and form the basis of decisions made regarding the reported amounts of assets and liabilities not evident by other means.
Estimates and assumptions are reviewed regularly. Changes in accounting estimates are recognized in the period when they are revised.
| Management has made assumptions and accounting estimates regarding the following items that materially impact the Group's financial statements: |
|||||
|---|---|---|---|---|---|
| '- Financial assets, see notes no. 12 and 26 | |||||
| '- Intangible assets, see note no. 17 | |||||
| '- Liability due to insurance contracts, see note no. 19 | |||||
| 5. Operating segment reporting |
|||||
| The Group is divided into three operating segments: Insurance operations, Insurance investments and Financial services, in accordance with the Group's organization and internal structure. Insurance operations include the VÍS insurance and Lífís life insurance business units. Insurance investments include the investment operations of the insurance business (VÍS and Lífís). Financial services include the operations of Fossar and SIV. The operating segments' results for the period 1 January to 30 September 2024 are specified as follows: |
|||||
| Insurance operations |
Insurance investments |
Financial services |
Skagi Supporting units and eliminations |
Total | |
| Insurance revenue Claims incurred Insurance contract operating expenses Net expenses from reinsurance contracts |
21.636.007 (15.869.322) (4.083.774) (640.491) |
21.636.007 (15.869.322) (4.083.774) (640.491) |
|||
| Insurance service result | 1.042.420 | 0 | 0 | 0 | 1.042.420 |
| Net interest income | 159.813 | (108.076) | 159.813 1.136.205 |
||
| Net fee and commission income | 1.244.280 | ||||
| Financial income Operating cost of the insurance investment portfolio Net finance expenses from insurance contracts |
2.011.091 (206.409) (920.226) |
27.591 | 2.038.682 (206.409) (920.226) |
||
| Other financial items Net financial income |
0 | (324.755) 559.701 |
27.591 | 0 | (324.755) 587.292 |
| Other operating income | 62.547 | 20.010 | (3.968) | 78.589 | |
| Net operating income | 1.104.967 | 559.701 | 1.451.694 | (112.044) | 3.004.318 |
| Operating expenses Net impairments |
(22.585) | (1.592.611) (9.450) |
(450.315) | (2.065.510) (9.450) |
|
| Profit (loss) before tax | 1.082.382 | 559.701 | (150.367) | (562.359) | 929.358 |
| Income tax expenses | (229.283) |
| Notes to the Condensed Consolidated Interim Financial Statements | |||||
|---|---|---|---|---|---|
| 5. Operating segment reporting (cont.) | |||||
| The operating segments' results for the period 1 January to 30 September 2023 are specified as follows: | |||||
| Insurance | Insurance | Financial | Skagi Supporting units |
||
| operations | Investments | services | and eliminations | Total | |
| Insurance revenue | 19.630.537 | 19.630.537 | |||
| Claims incurred Insurance contract operating expenses |
(14.864.283) (4.278.436) |
(14.864.283) (4.278.436) |
|||
| Net expenses from reinsurance contracts | (589.756) | (589.756) | |||
| Insurance service result | (101.938) | 0 | 0 | (101.938) | |
| Net interest income | 0 | ||||
| Net fee and commission income | 0 | ||||
| Financial income Operating cost of the insurance investment portfolio |
3.254.684 (239.198) |
3.254.684 (239.198) |
|||
| Net finance expenses from insurance contracts | (668.611) | (668.611) | |||
| Other financial items | (371.674) | (371.674) | |||
| Net financial income | 0 | 1.975.201 | 0 | 1.975.201 | |
| Other operating income | 55.251 | 22.510 | 77.761 | ||
| Net operating income | (46.687) | 1.975.201 | 22.510 | 0 | 1.951.023 |
| Operating expenses Net impairments |
(114.478) | (89.044) | (203.521) 0 |
||
| Profit (loss) before tax | (161.165) | 1.975.201 | (66.534) | 0 | 1.747.502 |
| Income tax expenses | (67.838) | ||||
| Profit for the period | 1.679.664 | ||||
| 6. Insurance service result |
|||||
| Insurance revenue | YTD 2024 | YTD 2023 | |||
| Premiums earned | 21.306.737 | 19.327.586 | |||
| Other insurance revenue | 329.270 | 302.951 | |||
| Insurance revenue | 21.636.007 | 19.630.537 | |||
| Insurance service expenses | |||||
| Claims incurred | (15.869.322) | (14.864.283) | |||
| Insurance contract operating expenses | (4.083.774) | (4.278.436) |
| Other operating income | 55.251 | 22.510 | 77.761 | |
|---|---|---|---|---|
| Net impairments | 0 | |||
| Income tax expenses | (67.838) | |||
| Profit for the period | 1.679.664 | |||
| 6. Insurance service result |
||||
| Premiums earned | 21.306.737 | 19.327.586 | ||
| Other insurance revenue | 329.270 | 302.951 | ||
| Insurance revenue | 21.636.007 | 19.630.537 | ||
| Insurance service expenses | ||||
| Claims incurred | (15.869.322) | (14.864.283) | ||
| Insurance contract operating expenses | (4.083.774) | (4.278.436) | ||
| Insurance service expenses | (19.953.096) | (19.142.719) | ||
| Net expenses from reinsurance contracts | ||||
| Premiums earned, reinsurers' share | (774.269) | (658.371) | ||
| Claims incurred, reinsurers' share | 128.572 | 63.722 | ||
| Fee and commission income from reinsurers | 5.207 | 4.893 | ||
| (640.491) | (589.756) | |||

| Interest income is specified as follows: | YTD 2024 |
|---|---|
| Bank deposits, cash, loans and other interest income | 359.945 |
| Derivatives | 439.315 |
| Interest on financial assets at fair value | 140.873 |
| Interest on financial assets recognized at fair value through other comprehensive income | 178.731 |
| Interest income, total | 1.118.864 |
| Money market loans and other borrowings | (754.389) |
| Issued bonds and bills | (195.996) |
| Interest expenses of leases | 1.258 |
| Other interest expenses | (9.924) |
| Interest expenses, total | (959.051) |
| Net interest income, total | 159.813 |
| YTD 2024 | |
|---|---|
| Capital markets and corporate finance | 767.718 |
| Asset management fees | 260.136 |
| Other net fee and commission income | 108.351 |
| Net fee and commission income, total | 1.136.205 |
| Net fee and commission income 8. |
|||
|---|---|---|---|
| YTD 2024 | |||
| Capital markets and corporate finance Asset management fees |
767.718 260.136 |
||
| Other net fee and commission income | 108.351 | ||
| Net fee and commission income, total | 1.136.205 | ||
| advisory, asset management, securities custody and credit. Net financial income 9. |
Fee and commission income includes fees for services provided to clients in the field of market trading, corporate | ||
| YTD 2024 | YTD 2023 | ||
| Interest income and other investment income | 298.594 | 448.297 | |
| Fair value change of equities* | (418.832) | 1.404.883 | |
| Fair value change of other financial assets* Fair value change of financial assets |
2.158.920 1.740.087 |
1.401.504 2.806.387 |
|
| Financial income, total | 2.038.682 | 3.254.684 | |
| Net finance expenses from insurance contracts | (920.226) | (668.611) | |
| Other financial items | (324.755) | (371.674) | |
| Operating cost of the insurance investment portfolio | (206.409) | (239.198) |
Interest income, finance expenses and other financial income above are from insurance investment operations.
| Notes to the Condensed Consolidated Interim Financial Statements | ||||
|---|---|---|---|---|
| 10. Operating expenses |
||||
| Salaries and related expenses | YTD 2024 3.944.103 |
YTD 2023 2.767.232 |
||
| Other operating expenses | 2.006.405 | 1.500.230 | ||
| Depreciation and amortisation | 405.185 | 453.694 | ||
| Total | 6.355.693 | 4.721.156 | ||
| Operating expenses of parent company | 450.315 | 0 | ||
| Operating expenses of financial services | 1.592.611 | 89.044 | ||
| Expenses of insurance operations | 4.106.359 | 4.392.914 | ||
| Operating cost of the insurance investment portfolio Operating expenses, total |
206.409 6.355.693 |
239.198 4.721.156 |
||
| Salaries and related expenses are specified as follows: | YTD 2024 | YTD 2023 | ||
| Salaries | 3.048.515 | 2.171.811 | ||
| Pension fund contributions Share option expenses* |
430.111 20.533 |
284.097 0 |
||
| Special financial activities tax on salaries | 191.352 | 128.778 | ||
| Other salary-related expenses | 253.591 | 182.546 | ||
| Salaries and salary-related expenses | 3.944.103 | 2.767.232 | ||
| Number of fulltime employees | 242 | 198 | ||
| *The 2023 general meeting of the company authorized the Board of directors to approve a share option plan in | ||||
| accordance with Article 10 of the Income Tax Act No. 90/2003 for all employees of Skagi (Vátryggingafélag Íslands) | ||||
| and its subsidiaries as for management as part of bonus scheme. | ||||
| 11. Income tax |
||||
| Income taxes are calculated and recognized in the financial statements. | ||||
| Effective tax rate: | YTD 2024 | YTD 2023 | ||
| Amount | % | Amount | % | |
| Profit before income taxes | 929.358 | 1.747.502 | ||
| Income tax according to prevailing tax rate Fair value changes of financial assets |
195.165 79.864 |
21,0% 8,6% |
349.500 (252.047) |
20,0% -14,4% |
| Non-deductible expenses | 10 | 0,0% | 9 | 0,0% |
| Dividends received | (50.198) | -5,4% | (28.929) | -1,7% |
| Effect of temporary change in tax rate | 3.825 | 0,4% | 0 | 0,0% |
| Other changes | 618 | 0,1% | (694) | 0,0% |
| accordance with Article 10 of the Income Tax Act No. 90/2003 for all employees of Skagi (Vátryggingafélag Íslands) and its subsidiaries as for management as part of bonus scheme. |
||||
|---|---|---|---|---|
| 11. Income tax |
||||
| Income taxes are calculated and recognized in the financial statements. | ||||
| Effective tax rate: | YTD 2024 | YTD 2023 | ||
| Amount | % | Amount | % | |
| Profit before income taxes | 929.358 | 1.747.502 | ||
| Income tax according to prevailing tax rate | 195.165 | 21,0% | 349.500 | 20,0% |
| Fair value changes of financial assets | 79.864 | 8,6% | (252.047) | -14,4% |
| Non-deductible expenses | 10 | 0,0% | 9 | 0,0% |
| Dividends received | (50.198) | -5,4% | (28.929) | -1,7% |
| Effect of temporary change in tax rate Other changes |
3.825 618 |
0,4% 0,1% |
0 (694) |
0,0% 0,0% |
| Notes to the Condensed Consolidated Interim Financial Statements | ||
|---|---|---|
| 12. Financial assets of insurance activities |
||
| Financial assets are specified as follows: | ||
| Shares in other companies | 30.9.2024 | 31.12.2023 |
| Listed on domestic stock exchanges | 3.175.148 | 3.852.460 |
| Listed on foreign stock exchanges | 3.073.373 | 1.896.105 |
| Other companies | 7.004.888 | 6.408.261 |
| 13.253.409 | 12.156.827 | |
| Other securities | ||
| Government-backed securities, indexed | 3.824.279 | 4.338.264 |
| Government-backed securities, non-indexed | 6.647.062 | 5.066.129 |
| Other bonds | 10.534.457 | 12.044.764 |
| Bond funds | 8.358.969 | 6.628.339 |
| Institutional investor funds | 2.432.616 | 2.524.266 |
| 31.797.383 | 30.601.762 | |
| Total financial assets | 45.050.792 | 42.758.589 |
| 13. Securities for hedging purposes |
||
| The carrying amounts of equities and securities held for hedging purposes are specified as follows: | ||
| 30.9.2024 | 31.12.2023 | |
| Government bonds and treasury bills | 1.298.168 | 991.441 |
| Shares | 3.629.684 | 2.877.705 |
| Other securities | 703.292 | 651.968 |
| 5.631.144 | 4.521.114 | |
| 14. Forward contracts |
||
| Assets | 30.9.2024 | 31.12.2023 |
| Derivatives shares | 187.366 | 126.986 |
| Derivatives bonds | 1.518 | 16.249 |
| 188.883 | 143.235 | |
| Liabilities |
| 30.9.2024 | 31.12.2023 | |
|---|---|---|
| Government bonds and treasury bills | 1.298.168 | 991.441 |
| Shares | 3.629.684 | 2.877.705 |
| Other securities . | 703.292 | 651.968 |
| 5 631 144 | 4 521 114 |
| 13. Securities for hedging purposes |
|||||
|---|---|---|---|---|---|
| The carrying amounts of equities and securities held for hedging purposes are specified as follows: | |||||
| 14. Forward contracts |
|||||
| Assets | 30.9.2024 | 31.12.2023 | |||
| Derivatives shares | 187.366 | 126.986 | |||
| Derivatives bonds | 1.518 | 16.249 | |||
| 188.883 | 143.235 | ||||
| Liabilities | |||||
| Derivatives shares Derivatives bonds |
226.124 18.557 |
194.563 21.052 |
|||
| 244.681 | 215.615 | ||||
| 15. Share in subsidiaries |
|||||
| 30.9.2024 | 31.12.2023 | Principal activity | |||
| VÍS tryggingar hf. | 100,0% | 100,0% | Seeking licence for insurance operations | ||
| Fossar fjárfestingarbanki hf. | 100,0% 100,0% |
100,0% | Investment banking | ||
| 100,0% | Investing activites | ||||
| VF Nord ehf. | |||||
| Líftryggingafélag Íslands hf. SIV eignastýring hf. |
100,0% 70,0% |
100,0% 70,0% |
Life insurance | Asset and fund management |
| Principal activity | |
|---|---|
| Seeking licence for insurance operations | |
| Investment banking | |
| Investing activites | |
| Life insurance | |
| Asset and fund management |

| Notes to the Condensed Consolidated Interim Financial Statements | |||||
|---|---|---|---|---|---|
| 16. Share in associates |
|||||
| Book value | Book value | ||||
| Tplús hf. | Share 35,0% |
30.9.2024 135.994 |
31.12.2023 151.393 |
||
| Vex ehf. | 35,0% | 38.889 | 38.889 | ||
| 174.883 | 190.283 | ||||
| 17. Intangible assets |
|||||
| Customer | |||||
| Cost | Goodwill | relationships | Brands | Software | Total |
| Notes to the Condensed Consolidated Interim Financial Statements | |||||
|---|---|---|---|---|---|
| 16. Share in associates |
|||||
| Tplús hf. | |||||
| Vex ehf. | |||||
| 174.883 | 190.283 | ||||
| 17. Intangible assets |
|||||
| Customer | |||||
| Cost | Goodwill | relationships | Brands | Software | Total |
| Cost at 1.1.2023 | 474.599 | 0 | 0 | 3.780.775 | 4.255.374 |
| Additions during the year Taken over due to acquisition of Fossar |
1.767.984 0 |
925.000 12.887 |
305.000 5.923 |
178.524 28.820 |
3.176.508 47.630 |
| Cost at 31.12.2023 | 2.242.583 | 937.887 | 310.923 | 3.988.119 | 7.479.512 |
| Additions during the period | 0 | 25.000 | 0 | 9.661 | 34.661 |
| Total cost 30.9.2024 | 2.242.583 | 962.887 | 310.923 | 3.997.780 | 7.514.173 |
| Amortisation | |||||
| Accumulated amortisation as at 1.1.2023 | 0 | 0 | 0 | 2.840.550 | 2.840.550 |
| Taken over due to acquisition of Fossar | 0 | 1.692 | 778 | 3.784 | 6.253 |
| Amortisation for the year Impairment |
0 0 |
23.125 0 |
7.625 0 |
313.121 805.628 |
343.871 805.628 |
| Accumulated amortisation as at 31.12.2023 | 0 | 24.817 | 8.403 | 3.963.083 | 3.996.302 |
| Amortisation for the period | 0 | 75.616 | 24.094 | 9.587 | 109.297 |
| Accumulated amortisation as at 30.9.2024 | 0 | 100.433 | 32.496 | 3.972.670 | 4.105.599 |
| Carrying amount | |||||
| Carrying amount at the beginning of the year 2023 | 474.599 | 0 | 0 | 940.225 | 1.414.824 |
| Carrying amount at year-end 2023 | 2.242.583 | 913.070 | 302.521 | 25.036 | 3.483.211 |
| Carrying amount as at 30.9.2024 | 2.242.583 | 862.454 | 278.427 | 25.110 | 3.408.574 |
| Amortisation rates | 0% | 10% | 10% | 10-33% | |
| The Group's goodwill stems from VIS's acquisition of Lífís in 2012 as well as the merger of Fossar Investment Bank in | |||||
| 2023. At year-end 2023, an annual impairment test was carried out on the goodwill in respect of Lífís, based on | |||||
| discounted future cash flow. The result of the test was that it was not necessary to write down the carrying amount | |||||
| of the goodwill. It is management opinion that there are no indicators of impairment of goodwill at the 30.9.2024 | |||||
| reporting date. | |||||
| 18. Other receivables | |||||
| Other receivables are specified as follows: | 30.9.2024 | 31.12.2023 | |||
| Prepaid taxes | 715.699 | 460.581 | |||
| Accrued interest income and prepaid expenses | 614.169 | 794.027 | |||
| Receivables related to domestic operations and other receivables Other receivables, total |
1.429.993 2.759.861 |
892.139 2.146.748 |
|||
| Prepaid taxes | |
|---|---|
| Accrued interest income and prepaid expenses | |
| Receivables related to domestic operations and other receivables | |
| Other receivables, total |

| Notes to the Condensed Consolidated Interim Financial Statements | ||
|---|---|---|
| 19. Insurance contract liabilities |
||
| Insurance contract liabilities are determined according to the accounting standard IFRS 17. | ||
| Insurance contract liabilities | 30.9.2024 | 31.12.2023 |
| Liability for remaining coverage Liability for incurred claims |
2.731.255 25.709.439 |
2.185.132 23.977.054 |
| Total insurance contract liabilities | 28.440.693 | 26.162.186 |
| Reinsurance contract assets | ||
| Reinsurance contracts assets | 1.322.546 | 1.229.156 |
| Insurance contract liabilities, net of reinsurance | ||
| Insurance contract liabilities, net of reinsurance | 27.118.147 | 24.933.030 |
| Changes in liabilities for incurred claims are specified as follows: | ||
| Liability for incurred claims, start of year | 23.977.054 | 22.880.803 |
| Net finance expenses from insurance contracts | 830.646 | 1.070.275 |
| Paid claims in the period due to older years | (7.664.614) | (9.787.018) |
| Liability for incurred claims, current year | 8.826.031 | 11.080.777 |
| Total calculated liability for incurred claims | 25.969.116 | 25.244.837 |
| Ruff off Change in risk adjustment |
(302.869) 43.191 |
(783.016) (484.767) |
| 20. Subordinated bond At the end of February 2016, the Company issued a subordinated bond in the nominal amount of ISK 2,500 million. |
||
|---|---|---|
| The bond is classified as Tier II capital and is included in the Company's solvency. The bond bears a fixed inflation indexed interest rate of 5.25%. Its maturity is 30 years but with a prepayment option and a step-up in interest rate to 6.25% ten years after the issue date. |
||
| 21.Accounts payable and other liabilities | ||
| Accounts payable are specified as follows: | 30.9.2024 | 31.12.2023 |
| Accounts payable | 1.446.714 | 785.401 |
| Income tax payable | 421.225 | 150.590 |
| Liabilities due to reinsurance activities Other liabilities |
184.735 1.981.340 |
67.623 2.156.160 |
| 20. Subordinated bond At the end of February 2016, the Company issued a subordinated bond in the nominal amount of ISK 2,500 million. |
||
|---|---|---|
| The bond is classified as Tier II capital and is included in the Company's solvency. The bond bears a fixed inflation indexed interest rate of 5.25%. Its maturity is 30 years but with a prepayment option and a step-up in interest rate to 6.25% ten years after the issue date. |
||
| 21.Accounts payable and other liabilities Accounts payable are specified as follows: |
30.9.2024 | 31.12.2023 |
| Accounts payable Income tax payable |
1.446.714 421.225 |
785.401 150.590 |
| Liabilities due to reinsurance activities | 184.735 | 67.623 |
| Other liabilities Accounts payable and other liabilities, total |
1.981.340 4.034.015 |
2.156.160 3.159.773 |

| Notes to the Condensed Consolidated Interim Financial Statements | |||
|---|---|---|---|
| 22. Share capital and equity reserves |
|||
| The share capital is specified as follows: | 30.9.2024 | 31.12.2023 | |
| Share capital according to the Company's Articles of Association Treasury shares |
1.906.700 (28.963) |
1.906.700 (1.150) |
|
| Share capital according to annual financial statements | 1.877.737 | 1.905.550 | |
| One vote is attached to each share of the nominal value of one Icelandic Krona in the Company. | |||
| According to the Limited Liability Companies Act, the Company is required to retain amounts corresponding to 25% |
| According to the Limited Liability Companies Act, the Company is required to retain amounts corresponding to 25% | ||
|---|---|---|
| of the nominal value of shares in a statutory reserve that is prohibited from being distributed as dividends to shareholders. Amounts in excess of 25% of the nominal value of shares are at the Company's disposal. |
||
| According to the Annual Accounts Act, the Company is to recognize unrealized fair value income of financial assets designated at fair value through profit or loss in a restricted reserve among equity which is not distributable as dividends. According to the Annual Accounts Act, the Company is to restrict the share in profit from a subsidiary and |
||
| associate in excess of dividends received. | ||
| Retained earnings consist of profit and loss of the Company not distributed as dividends or contributed to statutory reserve or other reserves. Retained earnings can be distributed to shareholders as dividends. However, solvency requirements limit the amounts the Company can pay as dividends. |
||
| 23. Fossar Capital adequacy ratio |
||
| The capital adequacy ratio of Fossar is calculated in accordance with Act No. 161/2002 on Financial Undertakings. The capital requirement due to credit, market, and operational risk is calculated using a standard method and the bank's capital adequacy ratio is 19,1%. |
||
| 30.9.2024 | 31.12.2023 | |
| Fossar total equity at period end | 1.859.182 | 1.925.908 |
| Deduction items | (302.950) | (218.894) |
| Own funds | 1.556.232 | 1.707.014 |
| Risk weighted exposures: Credit risk |
4.155.693 | 1.764.845 |
| Market risk | 1.635.395 | 1.417.711 |
| Total risk weighted exposure for part a, 3rd paragraph. Article 84 | 5.791.088 | 3.182.556 |
| Capital requirements for operational risk | 2.372.280 | 2.372.280 |
| Total risk weighted exposure for part b, 3rd paragraph. Article 84 | 2.372.280 | 2.372.280 |
| Total risk weighted assets for Article 84 | 8.163.368 | 5.554.836 |
| Notes to the Condensed Consolidated Interim Financial Statements | ||
|---|---|---|
| 24. Solvency of a financial conglomerate |
||
| It is assumed the approval of the Financial Supervisory Authority for defining the Group as a financial conglomerate as defined in Article 3 of Regulation No. 61/2017 on Supplementary Supervision of Financial Conglomerates will be obtained and the capital requirement of the Group is now calculated as the solvency ratio of a financial conglomerate. |
||
| The Group calculates the minimum capital requirements for companies that do not fall under the insurance operations using applicable regulations while using the Solvency II framework to calculate own funds and minimum own funds requirements for insurance activities. |
||
| Solvency is a measure of the Group's ability to absorb shocks, or in other words, an indication of its financial strength. The Group's available capital and capital requirements are calculated on the assumption that the Group meets the definition of a financial conglomerate according to Articles 16, 17 and 18 of Regulation No. 61/2017 on Supplementary Supervision of Financial Conglomerates. The Group's solvency ratio is 1,48 compared to the minimum requirement in the Regulation, which is 1.0. |
||
| 30.9.2024 | 31.12.2023 | |
| Solvency capital requirements for insurance activities | 12.825.142 | 11.866.623 |
| Solvency capital requirements for other activities | 1.138.568 | 742.873 |
| Total solvency capital requirements | 13.963.710 | 12.609.495 |
| Own funds for insurance activities | 19.025.936 | 19.317.148 |
| Own funds for other activities | 1.702.313 | 1.867.927 |
| Total own funds | 20.728.249 | 21.185.076 |
| Solvency ratio | 1,48 | 1,68 |
| 25. Solvency of insurance activities The minimum solvency is a minimum amount of capital needed to meet the risks faced by the Company. The standardized approach, according to Act No. 100/2016, is applied, whereby calculation is based on all measurable risks. The following tables specify how the solvency requirements are divided into subcomponents of risk. Diversification eƯects are deducted since it is not assumed that all risks will be realized simultaneously. An adjustment for the loss-absorbing capacity of deferred taxes is deducted upon realization of risks. |
||
| Solvency capital requirements | ||
| 30.9.2024 | 31.12.2023 | |
| Market risk | 7.765.004 | 6.683.185 |
| Counterparty risk | 1.988.050 | 1.820.181 |
| Insurance risk | 10.185.362 | 9.736.238 |
| Diversification effects and other factors | (7.113.275) | (6.372.981) |
| Total solvency capital requirements | 12.825.142 | 11.866.623 |
| Own funds | 19.025.936 | 19.317.148 |
| Solvency ratio | 1,48 | 1,68 |
|---|---|---|
| 25. Solvency of insurance activities |
||
| The minimum solvency is a minimum amount of capital needed to meet the risks faced by the Company. The standardized | ||
| approach, according to Act No. 100/2016, is applied, whereby calculation is based on all measurable risks. The following tables specify how the solvency requirements are divided into subcomponents of risk. Diversification eƯects are deducted since it is not assumed that all risks will be realized simultaneously. An adjustment for the loss-absorbing capacity of deferred taxes is deducted upon realization of risks. |
||
| Solvency capital requirements | ||
| 30.9.2024 | 31.12.2023 | |
| Market risk | 7.765.004 | 6.683.185 |
| Counterparty risk | 1.988.050 | 1.820.181 |
| Insurance risk | 10.185.362 | 9.736.238 |
| Diversification effects and other factors Total solvency capital requirements |
(7.113.275) 12.825.142 |
(6.372.981) 11.866.623 |
| Own funds | 19.025.936 | 19.317.148 |
| Solvency ratio | 1,48 | 1,63 |

| Financial instruments | ||||
|---|---|---|---|---|
| Notes to the Condensed Consolidated Interim Financial Statements 26. 26.1 Classification of financial instruments of insurance operations |
||||
| The Group's financial assets of insurance operations pertain to the following categories of financial instruments: | ||||
| 30.9.2024 | Financial | Financial | ||
| assets at fair | assets at | |||
| Financial assets | value | amortised cost | Total | Fair value |
| Equity and equity funds | 13.253.409 | 13.253.409 | 13.253.409 | |
| Debt instruments and other securities | 29.145.177 | 29.145.177 | 29.145.177 | |
| Secured debt instruments | 2.652.206 | 2.652.206 | ||
| Other receivables | 1.567.027 | 1.567.027 | ||
| Cash in escrow accounts and term deposits | 76.205 | 76.205 | ||
| Cash and cash equivalents | 1.313.147 | 1.313.147 | ||
| Financial assets, total | 42.398.586 | 5.608.586 | 48.007.172 | |
| 31.12.2023 | ||||
| Financial assets | ||||
| Equity and equity funds | 13.661.697 | 13.661.697 | 13.661.697 | |
| Debt instruments and other securities | 26.387.746 | 26.387.746 | 26.387.746 | |
| Secured debt instruments | 2.709.349 | 2.709.349 | ||
| 1.781.063 | 1.781.063 | |||
| Other receivables | 154.607 | 154.607 | ||
| Cash in escrow accounts and term deposits | 2.158.620 | |||
| Cash and cash equivalents | 2.158.620 |
| Equity and equity funds | 13.661.697 | 13.661.697 | |
|---|---|---|---|
| Debt instruments and other securities | 26.387.746 | 26.387.746 | |
| Secured debt instruments | 2.709.349 | 2.709.349 | |
| Other receivables | 1.781.063 | 1.781.063 | |
| Cash in escrow accounts and term deposits | 154.607 | 154 607 | |
| Cash and cash equivalents | 2.158.620 | 2.158.620 | |
| Financial assets, total |
| The carrying amounts of financial assets at amortised cost approximates their fair values. | ||||
|---|---|---|---|---|
| Fair value hierarchy of insurance operations | ||||
| The following table discloses financial assets at fair value or held-to-maturity according to valuation techniques. The valuation techniques are separated into three levels based on the significance of the assumptions made in determining fair value. The levels are as follows: |
||||
| Level 1: Quoted price in an active market for identical assets. | ||||
| Level 2: Fair value is not based on quoted prices in an active market (level 1) but on inputs that are observable for the asset, either directly (i.e. as prices) or indirectly (i.e. derived from prices). Financial assets for which there is not an active market are classified into level 2. The fair value assessment is based on recent transactions between unrelated parties or bid prices of unrelated parties. Comparison to similar financial assets is also applied. |
||||
| Level 3: Fair value measurement is based on significant inputs other than market value. Fair value measurement of financial assets classified as level 3 is based on inputs such as valuation from fund managers of investment or institutional investment funds, put options or the Company's valuation based on financial results or comparison to other similar financial assets. |
||||
| 30.9.2024 | Level 1 | Level 2 | Level 3 | Total |
| Financial assets at fair value | 28.778.599 | 2.223.214 | 11.396.773 | 42.398.586 |
| 31 December 2023 | Level 1 | Level 2 | Level 3 | Total |
| Financial assets at fair value | 27.394.439 | 1.054.670 | 11.600.335 | 40.049.444 |
| Changes that fall under level 3 during the period are specified as follows: | 30.9.2024 | 31.12.2023 | ||
| Balance 1.1. | 11.600.335 | 11.540.198 | ||
| Purchased | 1.574.118 | 2.371.195 | ||
| (1.624.166) | (3.781.357) |
| Fair value hierarchy of insurance operations | ||||
|---|---|---|---|---|
| The following table discloses financial assets at fair value or held-to-maturity according to valuation techniques. The valuation techniques are separated into three levels based on the significance of the assumptions made in determining fair value. The levels are as follows: |
||||
| Level 1: Quoted price in an active market for identical assets. | ||||
| Level 2: Fair value is not based on quoted prices in an active market (level 1) but on inputs that are observable for the asset, either directly (i.e. as prices) or indirectly (i.e. derived from prices). Financial assets for which there is not an active market are classified into level 2. The fair value assessment is based on recent transactions between unrelated parties or bid prices of unrelated parties. Comparison to similar financial assets is also applied. |
||||
| Level 3: Fair value measurement is based on significant inputs other than market value. Fair value measurement of financial assets classified as level 3 is based on inputs such as valuation from fund managers of investment or institutional investment funds, put options or the Company's valuation based on financial results or comparison to other similar financial assets. |
||||
| Financial assets at fair value | ||||
| 31 December 2023 | Level 1 | Level 2 | Level 3 | Total |
| Financial assets at fair value | 27.394.439 | 1.054.670 | 11.600.335 | 40.049.444 |
| Changes that fall under level 3 during the period are specified as follows: | 30.9.2024 | 31.12.2023 | ||
| Balance 1.1. | 11.600.335 | 11.540.198 | ||
| Purchased | 1.574.118 | 2.371.195 | ||
| Sold / Repayments | (1.624.166) | (3.781.357) | ||
| Moved between levels | 0 | (305.964) | ||
| Interest and fair value changes* | 1.776.264 | |||
| Balance at 30.9 | 11.396.773 | 11.600.335 | ||
| *Of which ISK 47 million is realised and ISK -201 million is unrealised. Interest and fair value changes are recorded among net financial income in the income statement. Condensed Consolidated Interim |
| Notes to the Condensed Consolidated Interim Financial Statements | ||||
|---|---|---|---|---|
| 26.2 Classification of financial instruments of financial services operations | ||||
| The Group's financial assets of financial services activities pertain to the following categories of financial instruments: | ||||
| 30.9.2024 | Fair value | Fair value | ||
| through | through | Amortised | ||
| Financial assets | profit or loss | OCI | cost | Total |
| Cash and cash equivalents | 522.949 | 522.949 | ||
| Other receivables (without prepayments) | 1.116.628 | 1.116.628 | ||
| Bonds | 2.547.324 | 3.026.954 | 5.574.278 | |
| Equities and other securities | 403.288 | 403.288 | ||
| Securities for hedging purposes | 5.631.144 | 5.631.144 | ||
| Loans to customers | 4.406.929 | 4.406.929 | ||
| Total | 8.581.756 | 3.026.954 | 6.046.506 | 17.655.217 |
| Financial liabilities | ||||
| Money market loans Issued bonds and bills |
9.274.046 3.563.529 |
9.274.046 3.563.529 |
||
| Liabilities to credit institutions | 1.399.242 | 1.399.242 | ||
| Accounts payable and other liabilities (without unpaid taxes) | 1.732.549 | 1.732.549 | ||
| Long-term loans | 24.256 | 24.256 | ||
| Total | 0 | 0 | 15.993.621 | 15.993.621 |
| 31 December 2023 | Fair value | Fair value | ||
| through | through | Amortised | ||
| Financial assets | profit or loss | OCI | cost | Total |
| Cash and cash equivalents | 112.073 | 112.073 | ||
| Other receivables (without prepayments) | 211.078 | 211.078 | ||
| Bonds | 1.904.654 | 2.657.469 | 4.562.123 | |
| Equities and other securities | 337.320 | 337.320 | ||
| Securities for hedging purposes | 4.521.114 | 4.521.114 | ||
| Loans to customers | 1.672.720 | 1.672.720 | ||
| Total | 6.763.087 | 2.657.469 | 1.995.872 | 11.416.428 |
| Financial liabilities Money market loans |
6.227.385 | 6.227.385 | ||
| Issued bonds and bills Liabilities to credit institutions |
2.285.315 700.000 |
2.285.315 700.000 |
| Other receivables (without prepayments) | ||||
|---|---|---|---|---|
| Bonds | ||||
| Equities and other securities | ||||
| Securities for hedging purposes | ||||
| Loans to customers | ||||
| Total | ||||
| Financial liabilities | ||||
| Money market loans | ||||
| Issued bonds and bills | ||||
| Liabilities to credit institutions | ||||
| Accounts payable and other liabilities (without unpaid taxes) | ||||
| Long-term loans | ||||
| Total | ||||
| Cash and cash equivalents | 112.073 | 112.073 | ||
| Other receivables (without prepayments) | 211.078 | 211.078 | ||
| Bonds | 1.904.654 | 2.657.469 | 4.562.123 | |
| Equities and other securities | 337.320 | 337.320 | ||
| Securities for hedging purposes | 4.521.114 | 4.521.114 | ||
| Loans to customers | 1.672.720 | 1.672.720 | ||
| Total | 6.763.087 | 2.657.469 | 1.995.872 | 11.416.428 |
| Financial liabilities | ||||
| Money market loans | 6.227.385 | 6.227.385 | ||
| Issued bonds and bills | 2.285.315 | 2.285.315 | ||
| Liabilities to credit institutions | 700.000 | 700.000 | ||
| Accounts payable and other liabilities (without unpaid taxes) | 292.507 | 292.507 | ||
| Long-term loans | 22.176 | 22.176 | ||
| Total | 0 | 0 | 9.527.383 | 9.527.383 |
| Fair value hierarchy of financial services operations The following table shows a breakdown of the carrying amounts of financial assets at fair value by valuation method: |
||||
| 30. september 2024 | Level 1 | Level 2 | Level 3 | Total |
| Investment in listed companies | 4.032.973 | 4.032.973 | ||
| Investment in bonds | 7.472.809 | 7.472.809 | ||
| Holdings in other companies, total | 11.505.781 | 0 | 0 | 11.505.781 |
| Level 1 | Level 2 | Level 3 | Total | |
| 31 December 2023 | 3.215.025 | 3.215.025 | ||
| 6.102.592 | ||||
| Investment in listed companies | ||||
| Investment in bonds Holdings in other companies, total |
6.102.592 9.317.617 |
0 | 0 | 9.317.617 |
| Investment in listed companies | ||
|---|---|---|
| Investment in bonds | ||
| Holdings in other companies, total | ||
| Investment in listed companies | ||
| Investment in bonds | ||
| Holdings in other companies, total |
| Notes to the Condensed Consolidated Interim Financial Statements 27.Credit quality of financial assets |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| 27.1 Breakdown of loans to customers by industry and information on collateral and other credit enhancements | |||||||||
| Allocated collateral | |||||||||
| 30.9.2024 | Claim value |
Impairment to expected credit loss |
Carrying amount |
Total collateral |
Deposits | Listed liquid funds |
Unlisted securities and securities and other funds |
Residental and Commercial real estate |
Other |
| Public entities Financial institutions Corporate |
|||||||||
| Real estate activities Construction |
292.686 302.282 |
(1.651) (519) |
291.035 301.763 |
459.900 3.205.250 |
459.900 3.138.000 |
0 67.250 |
|||
| Service activities Accommodat. and Food Service Activit. Activities of Holding Companies |
0 224.445 3.421.283 |
0 (1.218) (5.495) |
0 223.227 3.415.788 |
0 2.376.335 9.060.406 |
37.647 | 3.862.656 | 2.091.335 1.561.489 |
0 285.000 1.412.900 |
0 0 2.185.714 |
| Wholesale and Retail Trade Other Individual |
0 175.683 |
0 (567) |
0 175.116 |
0 540.000 |
0 540.000 |
||||
| Total | 4.416.379 | (9.450) | 4.406.929 | 15.641.891 | 37.647 | 3.862.656 | 1.561.489 | 5.295.800 | 2.792.964 |
| Allocated collateral | |||||||||
| Impairment | Listed | Unlisted | |||||||
| 31.12.2023 | Claim value |
to expected credit loss |
Carrying amount |
Total collateral |
Deposits | liquid funds | securities and securities and other funds |
Commercial real estate |
Other |
| Public entities Financial institutions Corporate |
|||||||||
| Real estate activities Construction |
14.994 | 14.994 | 67.500 | 67.500 |
| Claim | to expected | Carrying | Total | Commercial | |||||
|---|---|---|---|---|---|---|---|---|---|
| value | credit loss | amount | collateral | Deposits | liquid funds | other funds | real estate | Other | |
| 14.994 | 14.994 | 67.500 | 67.500 | ||||||
| 150.967 1.506.759 |
150.967 1.506.759 |
4.080.000 3.728.145 |
3.208 | 2.680.526 | 1.044.411 | 4.080.000 | |||
| Allocated collateral | securities and securities and |
Condensed Consolidated Interim

| Notes to the Condensed Consolidated Interim Financial Statements | ||||
|---|---|---|---|---|
| 27.2 Credit quality of loans to customers by credit quality band | ||||
| The following tables show financial assets subject to the impairment requirements of IFRS 9 broken down by credit quality bands where band I denotes the lowest and band IV the highest credit risk. The Bank has primarily used adjusted external credit ratings to assess the default probability of its customers. |
||||
| Credit quality of financial assets by credit quality band 30.9.2024 |
||||
| Loans to customers: | Stage 1 | Stage 2 | Stage 3 | Total |
| Credit quality band I Credit quality band II Credit quality band III Credit quality band IV In default |
4.289.980 126.399 |
4.289.980 126.399 |
||
| Non-Rated Gross carrying amount |
4.416.379 | 0 | 0 | 4.416.379 |
| Expected credit loss | (9.450) | (9.450) | ||
| Book value | 4.406.929 | 0 | 0 | 4.406.929 |
| 31.12.2023 | ||||
| Loans to customers: | Stage 1 | Stage 2 | Stage 3 | Total |
| Credit quality band I Credit quality band II Credit quality band III |
1.505.956 166.764 |
1.505.956 166.764 |
||
| Credit quality band IV In default |
||||
| Non-Rated Gross carrying amount Expected credit loss |
1.672.720 | 0 | 0 | 1.672.720 0 |
| Credit quality band IV | ||||
|---|---|---|---|---|
| In default | ||||
| Non-Rated | ||||
| Gross carrying amount | ||||
| Expected credit loss | ||||
| Book value | ||||
| 31.12.2023 | ||||
| Credit quality band I | ||||
| Credit quality band II | ||||
| Credit quality band III | ||||
| Credit quality band IV | ||||
| In default | ||||
| Non-Rated Gross carrying amount |
||||
| Expected credit loss | 0 | |||
| Book value | 1.672.720 | 0 | 0 | 1.672.720 |
| 27.3 Breakdown of loans to customers into not past due and past due | ||||
| 30.9.2024 | Claim | Expected | ||
| value | credit loss | Book value | ||
| Not past due | 4.416.379 | (9.450) | 4.406.929 | |
| Past due 1-30 days | ||||
| Past due 31-60 days | ||||
| Past due 61-90 days | ||||
| Past due 91-180 days | ||||
| Credit quality band I | |||
|---|---|---|---|
| Credit quality band II | |||
| Credit quality band III | |||
| Credit quality band IV In default |
|||
| Non-Rated | |||
| Gross carrying amount | |||
| Expected credit loss | 0 | ||
| Book value | |||
| 27.3 Breakdown of loans to customers into not past due and past due | |||
| Not past due | |||
| Past due 1-30 days | |||
| Past due 31-60 days | |||
| Past due 61-90 days | |||
| Past due 91-180 days | |||
| Past due 181-360 days | |||
| Past due more than 360 days | |||
| Total | 4.416.379 | (9.450) | 4.406.929 |
| 31.12.2023 | Claim | Expected | |
| value | credit loss | Book value | |
| Not past due | 1.672.720 | 0 | 1.672.720 |
| Past due 1-30 days | |||
| Past due 31-60 days | |||
| Past due 61-90 days | |||
| Past due 91-180 days | |||
| Not past due | |||
|---|---|---|---|
| Past due 1-30 days | |||
| Past due 31-60 days | |||
| Past due 61-90 days | |||
| Past due 91-180 days | |||
| Past due 181-360 days | |||
| Past due more than 360 days | |||
| Total | |||
| Not past due | |||
| Past due 1-30 days | |||
| Past due 31-60 days | |||
| Past due 61-90 days | |||
| Past due 91-180 days | |||
| Past due 181-360 days | |||
| Past due more than 360 days | |||
| Total | 1.672.720 | 0 | 1.672.720 |
| Condensed Consolidated Interim | |||
| Financial Statements 30 September 2024 25 |
All amounts are in thousands of ISK |

| Notes to the Condensed Consolidated Interim Financial Statements | ||||
|---|---|---|---|---|
| 27.4 Allowance for expected credit loss on loans to customers and on loan commitments, guarantees and unused credit facilities during the period |
||||
| The following tables show changes in the expected credit loss allowance of loans to customers and for loan commitments, guarantees and unused credit facilities during the period. |
||||
| 30.9.2024 Expected credit loss allowance total |
||||
| Transfer of financial assets: | Stage 1 | Stage 2 | Stage 3 | Total |
| Balance as at 1 January 2024 Transfer to Stage 1 Transfer to Stage 2 Transfer to Stage 3 |
2.049 | 2.049 | ||
| Net remeasurement of loss allowance New financial assets, originated or purchased Derecognitions and maturities Write-offs |
538 6.863 |
538 6.863 |
||
| Balance as at 30 September 2024 | 9.450 | 0 | 0 | 9.450 |
| 31.12.2023 | ||||
| Transfer of financial assets: | Stage 1 | Stage 2 | Stage 3 | Total |
| Balance as at 1 January 2023 Transfer to Stage 1 Transfer to Stage 2 Transfer to Stage 3 |
838 | 838 | ||
| Net remeasurement of loss allowance New financial assets, originated or purchased Derecognitions and maturities |
2.099 | 2.099 | ||
| Write-offs Balance as at 31 December 2023 |
(888) 2.049 |
0 | 0 | (888) 2.049 |
| 28. Loan-to-value The loan-to-value ratio (LTV) is the ratio of the gross amount of the loan to the value of the collateral, if any. The general creditworthiness of a customer is viewed as the most reliable indicator of credit quality of a loan. Besides collateral included in the LTV ratios the Group uses other risk mitigation measures, such as guarantees, negative pledge, cross-collateral and collateralization of non-quantifiable assets. The breakdown of loans to customers by LTV is specified as follows: Less than 50% 51-70% |
30.9.2024 1.698.874 2.467.681 |
% 39% 56% |
31.12.2023 662.273 809.305 |
% 40% 48% |
| 71-90% 91-100% 101-125% 126-200% |
240.374 Greater than 200% |
5% | 201.142 | 12% |
| Transfer to Stage 1 Transfer to Stage 2 |
||||
|---|---|---|---|---|
| Transfer to Stage 3 Net remeasurement of loss allowance New financial assets, originated or purchased |
||||
| Derecognitions and maturities | ||||
| Write-offs | ||||
| 28. Loan-to-value |
||||
| The loan-to-value ratio (LTV) is the ratio of the gross amount of the loan to the value of the collateral, if any. The general creditworthiness of a customer is viewed as the most reliable indicator of credit quality of a loan. Besides collateral included in |
||||
| the LTV ratios the Group uses other risk mitigation measures, such as guarantees, negative pledge, cross-collateral and collateralization of non-quantifiable assets. The breakdown of loans to customers by LTV is specified as follows: |
||||
| 30.9.2024 | % | 31.12.2023 | % | |
| Less than 50% | 1.698.874 | 39% | 662.273 | 40% |
| 51-70% | 2.467.681 | 56% | 809.305 | 48% |
| 71-90% 91-100% 101-125% |
240.374 | 5% | 201.142 | 12% |
| 126-200% Greater than 200% No or negligible collateral: Other loans with no collateral |

The maximum exposure to credit risk for on-balance sheet and oƯ-balance sheet items, before taking into account any collateral held or other credit enhancements, is specified as follows:
| On and off balance sheet exposure | Public entities |
Financial institutions |
Corporate customers |
Individuals | Total |
|---|---|---|---|---|---|
| Cash and balances with Central Bank | 517.291 | 517.291 | |||
| Fixed income securities | 5.631.144 | 5.631.144 | |||
| Loans to customers | 4.406.929 | 4.406.929 | |||
| Derivatives | 188.883 | 188.883 | |||
| Other assets | 258.925 | 258.925 | |||
| Total | 5.631.144 | 517.291 | 4.854.738 | 0 | 11.003.173 |
| On and off balance sheet exposure | Public entities |
Financial institutions |
Corporate customers |
Individuals | Total |
|---|---|---|---|---|---|
| Cash and balances with Central Bank | 112.073 | 112.073 | |||
| Fixed income securities | 5.450.624 | 651.968 | 6.102.592 | ||
| Loans to customers | 1.672.720 | 1.672.720 | |||
| Derivatives | 143.234 | 143.234 | |||
| Other assets | 211.078 | 211.078 | |||
| Total | 5.450.624 | 112.073 | 2.679.000 | 0 | 8.241.697 |
| Notes to the Condensed Consolidated Interim Financial Statements | |||||||
|---|---|---|---|---|---|---|---|
| 30.Collateral against exposures to derivatives | |||||||
| The Group applies the same valuation methods to collateral held as other comparable assets held by the Group. Haircuts are applied to the market value of the collateral for liquidity | |||||||
| and other factors which may aƯect the applied collateral value of the asset. | |||||||
| Market value of collateral | |||||||
| Notional amount |
Notional amount |
Total | Fixed | Variable | |||
| fixed income | variable income | notional | income | income | Total | ||
| 30.9.2024 | securities | securities | amount | Deposits | Securities | securities | collateral |
| Financial institutions | 881.814 | 2.637.097 | 3.518.911 | 185.421 | 239.851 | 180.744 | 606.016 |
| Corporate customers | 4.704.636 | 320.402 | 5.025.038 | 274.457 | 2.975.014 | 866.895 | 4.116.366 |
| Individuals | 5.586.450 | 2.957.499 | 8.543.949 | 459.878 | 3.214.865 | 1.047.639 | 4.722.382 |
| Market value of collateral | |||||||
| Notional | Notional | ||||||
| amount | amount | Total | Fixed | Variable | |||
| variable income | notional | income Securities |
income securities |
Total collateral |
|||
| fixed income | |||||||
| 31.12.2023 | securities | securities | amount | Deposits | |||
| Financial institutions | 157.081 | 1.336.746 | 1.493.827 | 42.465 | 0 | 0 | 42.465 |
| Corporate customers Individuals |
4.766.714 0 |
552.748 237.628 |
5.319.462 237.628 |
760.846 15.132 |
209.600 0 |
2.002.550 0 |
2.972.996 15.132 |
| Market value of collateral | |||||
|---|---|---|---|---|---|

| Notes to the Condensed Consolidated Interim Financial Statements | |||||
|---|---|---|---|---|---|
| 31. Large exposure |
|||||
| 30.9.2024 | 31.12.2023 | ||||
| Large exposure before risk adjusted mitigation | Number | Amount | Number | Amount | |
| 10-20% of capital base | 6 | 1.478.679 | 0 | 0 | |
| 20-25% of capital base | 0 | 0 | 0 | ||
| Exceeding 25% of capital base | 0 | 0 | 0 | ||
| Total | 6 | 1.478.679 | 0 | 0 | |
| Large exposure net of risk adjusted mitigation | 6 | 1.230.442 | 0 | 0 | |
| 32. Key ratios |
|||||
| The combined ratio is the sum of incurred claims, operating expenses and net reinsurance cost as a proportion of insurance | |||||
| revenue. The claims ratio, operating ratio and net reinsurance ratio are calculated as a proportion of the insurance revenue for the | |||||
| period. | |||||
| The following table shows the combined ratio and other key figures of the insurance operations and the Group. For further | |||||
| information on solvency ratios, reference is made to notes 24-25. | |||||
| Key ratios for insurance business | 30.9.2024 | 30.9.2023 | |||
| Claims ratio | 73,3% | 75,7% | |||
| Net reinsurance ratio | 3,0% | 3,0% | |||
| 76,3% | 78,7% | ||||
| Claims and net reinsurance ratio | 18,9% | 21,8% | |||
| Insurance contracts expense ratio | |||||
| Combined ratio | 95,2% | 100,5% | |||
| Solvency ratio for insurance business | 1,48 | 1,53 | |||
| Key ratios for the Group | |||||
| ROE on annual basis | 3,9% | 13,1% |
| 10-20% of capital base 20-25% of capital base Exceeding 25% of capital base Total |
|||
|---|---|---|---|
| Large exposure net of risk adjusted mitigation | |||
| Claims ratio 73,3% |
75,7% | ||
| Net reinsurance ratio 3,0% |
3,0% | ||
| Claims and net reinsurance ratio 76,3% |
78,7% | ||
| Insurance contracts expense ratio 18,9% Combined ratio 95,2% |
21,8% 100,5% |
||
| Solvency ratio for insurance business 1,48 |
1,53 | ||
| ROE on annual basis 3,9% |
13,1% | ||
| information on solvency ratios, reference is made to notes 24-25. | 30.9.2024 30.9.2023 |
The combined ratio is the sum of incurred claims, operating expenses and net reinsurance cost as a proportion of insurance revenue. The claims ratio, operating ratio and net reinsurance ratio are calculated as a proportion of the insurance revenue for the The following table shows the combined ratio and other key figures of the insurance operations and the Group. For further |
| Key ratios for the Group | ||||
|---|---|---|---|---|
| 33.Related parties Related parties are those parties, or their companies, that have a significant influence on the Group, whether directly or indirectly. Related parties are board members of the Group, the CEOs of the Group, key management personnel, associates, close family |
||||
| members of individuals identified as related parties, as well as other dependent parties directed by or under the influence of the Group. Transactions with related parties have been on the same terms as with unrelated parties. Transactions and balances with related parties are specified as follows: |
||||
| 1.1-30.9.2024 | 30.9.2024 | |||
| Board of directors and key management | Income 2.895 |
Expenses 36.249 |
Assets 388.153 |
Liabilities 12.297 |
| 1.1-30.9.2023 | 31.12.2023 | |||
| Income | Expenses | Assets | Liabilities |
| Notes to the Condensed Consolidated Interim Financial Statements | ||||||||
|---|---|---|---|---|---|---|---|---|
| 34. Events after the reporting date |
||||||||
| No events have occurred after the end of the reporting period that require the Group to change these financial statements. It is however noted that capital allocations within the Group have been concluded in November, in terms of (a) on 1st November an equity share capital increase was completed from Skagi to Fossar fjárfestingarbanki hf. in the amount of ISK 200 million, to support growth of the bank; and (b) on 11th November the acquisition of Íslensk verðbréf hf. with initial (1st) payment of ISK 1,579 million to sellers of 98.07% share capital in ÍV was concluded. The 2nd and final payment to sellers of Íslensk verðbréf is expected to be made on 11th January 2025 in the amount of 25 million, subject to certain conditions. |
||||||||
| 35. Quarterly statement |
||||||||
| Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | ||||
| Insurance revenue | 7.634.285 | 7.212.980 | 6.788.741 | 6.843.539 | 6.952.232 | |||
| Investment result after financial items | 119.137 | (31.026) | 499.182 | 845.132 | 396.871 | |||
| Net interest and commission income | 367.801 | 336.078 | 592.138 | 391.452 | 37.891 | |||
| Share in the profit of aff., after income tax | 0 | 0 | 0 | 9.191 | 0 | |||
| Other income | 16.617 | 37.270 | 24.702 | 17.337 | 14.584 | |||
| Total income | 8.137.840 | 7.555.303 | 7.904.763 | 8.106.650 | 7.401.578 | |||
| Insurance service expenses | (6.857.014) | (6.267.195) | (6.828.887) | (6.641.423) | (6.344.821) | |||
| Net expenses from reinsurance contracts | (187.636) | (250.375) | (202.480) | 42.994 | (238.933) | |||
| (651.993) | (749.283) | (664.235) | (658.669) | (105.464) | ||||
| Operating expenses | (650) | (1.893) | (6.907) | (805.628) | 0 | |||
| Impairment of intangible assets | 202.254 | 43.924 | 712.360 | |||||
| Profit before income taxes | 440.547 | 286.557 | ||||||
| Income tax | (13.330) | (149.213) | (66.740) | 108.016 | (104.888) | |||
| Profit for the period | 427.217 | 137.344 | 135.514 | 151.940 | 607.471 | |||
| Claims ratio | 73,5% | 67,2% | 79,7% | 73,3% | 72,6% | |||
| Net reinsurance ratio | 2,5% | 3,5% | 3,0% | -0,6% | 3,4% | |||
| Claims and net reinsurance ratio | 76,0% | 70,7% | 82,6% | 72,6% | 76,0% | |||
| Insurance contracts expense ratio | 16,3% | 19,7% | 20,9% | 23,8% | 18,7% |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.